289 related articles for article (PubMed ID: 23012369)
21. Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.
Plan MR; Rosengren KJ; Sando L; Daly NL; Craik DJ
Biopolymers; 2010; 94(5):647-58. PubMed ID: 20564013
[TBL] [Abstract][Full Text] [Related]
22. Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity.
Barry DG; Daly NL; Clark RJ; Sando L; Craik DJ
Biochemistry; 2003 Jun; 42(22):6688-95. PubMed ID: 12779323
[TBL] [Abstract][Full Text] [Related]
23. In-Silico Template Selection of In-Vitro Evolved Kalata B1 of Oldenlandia Affinis for Scaffolding Peptide-Based Drug Design.
Senthilkumar B; Kumar P; Rajasekaran R
J Cell Biochem; 2016 Jan; 117(1):66-73. PubMed ID: 26052694
[TBL] [Abstract][Full Text] [Related]
24. Capped acyclic permutants of the circular protein kalata B1.
Simonsen SM; Daly NL; Craik DJ
FEBS Lett; 2004 Nov; 577(3):399-402. PubMed ID: 15556617
[TBL] [Abstract][Full Text] [Related]
25. Discovery and in vivo evaluation of new melanocortin-4 receptor-selective peptides.
Nijenhuis WA; Kruijtzer JA; Wanders N; Vrinten DH; Garner KM; Schaaper WM; Meloen RH; Gispen WH; Liskamp RM; Adan RA
Peptides; 2003 Feb; 24(2):271-80. PubMed ID: 12668212
[TBL] [Abstract][Full Text] [Related]
26. Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism.
Gründemann C; Thell K; Lengen K; Garcia-Käufer M; Huang YH; Huber R; Craik DJ; Schabbauer G; Gruber CW
PLoS One; 2013; 8(6):e68016. PubMed ID: 23840803
[TBL] [Abstract][Full Text] [Related]
27. Structure and function of the potent cyclic and linear melanocortin analogues.
Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
[TBL] [Abstract][Full Text] [Related]
28. Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.
Fleming KA; Ericson MD; Freeman KT; Adank DN; Lunzer MM; Wilber SL; Haskell-Luevano C
ACS Chem Neurosci; 2018 May; 9(5):1141-1151. PubMed ID: 29363944
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.
Cascales L; Henriques ST; Kerr MC; Huang YH; Sweet MJ; Daly NL; Craik DJ
J Biol Chem; 2011 Oct; 286(42):36932-43. PubMed ID: 21873420
[TBL] [Abstract][Full Text] [Related]
30. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
Ericson MD; Koerperich ZM; Freeman KT; Fleming KA; Haskell-Luevano C
ACS Chem Neurosci; 2018 Dec; 9(12):3015-3023. PubMed ID: 29924583
[TBL] [Abstract][Full Text] [Related]
31. Late-Stage Functionalization with Cysteine Staples Generates Potent and Selective Melanocortin Receptor-1 Agonists.
White AM; Dellsén A; Larsson N; Kaas Q; Jansen F; Plowright AT; Knerr L; Durek T; Craik DJ
J Med Chem; 2022 Oct; 65(19):12956-12969. PubMed ID: 36167503
[TBL] [Abstract][Full Text] [Related]
32. Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(
Schlasner KN; Ericson MD; Doering SR; Freeman KT; Weinrich M; Haskell-Luevano C
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013889
[TBL] [Abstract][Full Text] [Related]
33. Improved method for quantitative analysis of the cyclotide kalata B1 in plasma and brain homogenate.
Melander E; Eriksson C; Jansson B; Göransson U; Hammarlund-Udenaes M
Biopolymers; 2016 Nov; 106(6):910-916. PubMed ID: 27603276
[TBL] [Abstract][Full Text] [Related]
34. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
35. Novel approaches to the design of bioavailable melanotropins.
Zhou Y; Cai M
Expert Opin Drug Discov; 2017 Oct; 12(10):1023-1030. PubMed ID: 28699792
[TBL] [Abstract][Full Text] [Related]
36. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
37. Gly(6) of kalata B1 is critical for the selective binding to phosphatidylethanolamine membranes.
Hall K; Lee TH; Daly NL; Craik DJ; Aguilar MI
Biochim Biophys Acta; 2012 Sep; 1818(9):2354-61. PubMed ID: 22538355
[TBL] [Abstract][Full Text] [Related]
38. The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured.
Daly NL; Gunasekera S; Clark RJ; Lin F; Wade JD; Anderson MA; Craik DJ
Biopolymers; 2016 Nov; 106(6):825-833. PubMed ID: 27564841
[TBL] [Abstract][Full Text] [Related]
39. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
[TBL] [Abstract][Full Text] [Related]
40. Minimization of MC1R selectivity by modification of the core structure of alpha-MSH-ND.
Lim S; Li S; Lee C; Yoon C; Baik J; Lee W
Chem Biol; 2001 Sep; 8(9):857-70. PubMed ID: 11564554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
